Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frank Vanmiddlesworth is active.

Publication


Featured researches published by Frank Vanmiddlesworth.


Tetrahedron Letters | 1993

The zaragozic acids: Structure elucidation of a new class of squalene synthase inhibitors

Otto D. Hensens; Claude Dufresne; Jerrold M. Liesch; Deborah L. Zink; Robert A. Reamer; Frank Vanmiddlesworth

Structures of two novel fungal metabolites, zaragozic acids A (1) and B (2), characterized by a novel 2,8-dioxobicyclo[3.2.1] octane-4,6,7-trihydroxy-3,4,5-tricar☐ylic acid core, are proposed predominantly on the basis of 2D NMR.


Tetrahedron | 1991

Structure elucidation of restricticin, a novel antifungal agent from penicillium restrictum

Otto D. Hensens; Carol F. Wichmann; Jerrold M. Liesch; Frank Vanmiddlesworth; Kenneth E. Wilson; Robert E. Schwartz

Abstract The structures and absolute stereochemistry of restricticin (1), its N,N-dimethyl derivative (4) and desglycyl hydrolysis product (3), isolated from Penicillium restrictum, have been determined on the basis of spectroscopic evidence. They belong to a new class of broad spectrum antifungal agents representing substituted tetrahydropyranyl ethers incorporating triene and glycyl ester side chains.


Tetrahedron | 1991

Structure elucidation of L-687,781, a new β-1,3-D-glucan synthesis inhibitor.

Frank Vanmiddlesworth; Claude Dufresne; Jack L. Smith; Kenneth E. Wilson

Abstract A new β-1,3 glucan synthesis inhibitor, L-687,781 is produced by the cultivation of Dictyochaeta simplex ATCC 20960. Through NMR, mass spectroscopy, and degradation studies the structure of L-687,781 was determined to be 1 , a novel member of the papulacandin family of antifungal agents. L-687,781 exhibits potent in vitro antifungal activity as well as anti-Pneumocystis activity in a rat model.


Proceedings of the National Academy of Sciences of the United States of America | 1993

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase

James D. Bergstrom; Marc M. Kurtz; D J Rew; A M Amend; J D Karkas; Richard G. Bostedor; V S Bansal; Claude Dufresne; Frank Vanmiddlesworth; O D Hensens


Proceedings of the National Academy of Sciences of the United States of America | 1990

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Dennis M. Schmatz; M A Romancheck; L A Pittarelli; Robert E. Schwartz; Robert A. Fromtling; Karl H. Nollstadt; Frank Vanmiddlesworth; Kenneth E. Wilson; M J Turner


The Journal of Antibiotics | 1991

L-687,781, a new member of the papulacandin family of beta-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity.

Frank Vanmiddlesworth; Mary Nallin Omstead; Dennis M. Schmatz; Ken Bartizal; Robert A. Fromtling; Gerald F. Bills; Karl H. Nollstadt; Susan S. Honeycutt; Marcia Zweerink; George M. Garrity; Kenneth E. Wilson


Archive | 1990

Novel squalene synthetase inhibitors

James D. Bergstrom; Otto D. Hensens; Leeyuan Huang; Jerrold M. Liesch; Janet C. Onishi; Frank Vanmiddlesworth


Journal of Organic Chemistry | 1992

Chemicoenzymatic synthesis of lysofungin

Frank Vanmiddlesworth; Maria Lopez; Marcia Zweerink; Ann M. Edison; Kenneth E. Wilson


Journal of Organic Chemistry | 1992

Chemicoenzymic synthesis of lysofungin

Frank Vanmiddlesworth; Maria Lopez; Marcia Zweerink; Ann M. Edison; Kenneth E. Wilson


The Journal of Antibiotics | 1996

CARBAZATE AS A GLYCINE BIOISOSTERE IN RESTRICTICIN

Frank Vanmiddlesworth; Jim Milligan; Ken Bartizal; Claude Dufresne; Jan Onishi; George K. Abruzzo; Art Patchett; Kenneth E. Wilson

Researchain Logo
Decentralizing Knowledge